Prelude Capital Management’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,900
Closed -$175K 1549
2024
Q1
$175K Buy
+10,900
New +$230K 0.01% 1137
2020
Q3
Sell
-6,800
Closed -$558K 2442
2020
Q2
$558K Buy
+6,800
New +$460K 0.03% 452

Other funds holding ZLAB

Prelude Capital Management's ZLAB Position: Q2 2024 in Review

Prelude Capital Management sold out of Zai Lab (ZLAB) in Q2 2024, closing a stake of 10,900 shares — an estimated $175K sold.

Prelude Capital Management first reported a position in ZLAB in Q2 2020 and held it in 2 quarters. The position peaked at $558K in Q2 2020. 105 funds tracked by Wall St. Rank hold ZLAB as of Q2 2024.

  • Prelude Capital Management reported no remaining Zai Lab position as of Q2 2024 after selling out during the quarter.
  • Prelude Capital Management sold 10,900 Zai Lab shares in Q2 2024, an estimated $175K.
  • Prelude Capital Management first reported a position in Zai Lab in Q2 2020 and held it in 2 quarters.
  • Prelude Capital Management's Zai Lab position peaked at $558K in Q2 2020.
  • 105 funds tracked by Wall St. Rank held Zai Lab as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.